Summit Therapeutics (SMMT) Tops Q3 EPS by 2c
Tweet
Share
E-mail
Get Alerts SMMT Hot Sheet
Join SI Premium – FREE
Summit Therapeutics (NASDAQ: SMMT) reported Q3 EPS of (GBP0.05), GBP0.02 better than the analyst estimate of (GBP0.07).
For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Summit Therapeutics plc (SMMT) PT Raised to $9.80 at Bernstein SocGen Group
- Hyperscale Data reports Bitcoin treasury of 726.9 BTC worth $45.9M
- Gyre Therapeutics (GYRE) files for 30.22M share offering by selling stockholders
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
